SG120901A1 - Process for making 1,3-disubstituted-4-oxocyclic ureas - Google Patents

Process for making 1,3-disubstituted-4-oxocyclic ureas

Info

Publication number
SG120901A1
SG120901A1 SG200207219A SG200207219A SG120901A1 SG 120901 A1 SG120901 A1 SG 120901A1 SG 200207219 A SG200207219 A SG 200207219A SG 200207219 A SG200207219 A SG 200207219A SG 120901 A1 SG120901 A1 SG 120901A1
Authority
SG
Singapore
Prior art keywords
disubstituted
making
oxocyclic ureas
oxocyclic
ureas
Prior art date
Application number
SG200207219A
Other languages
English (en)
Inventor
Patricia Ann Matson
Michael Selden Godlewski
Daniel Quarroz
Yves Guggisberg
Original Assignee
Procter & Gamble
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble, Lonza Ag filed Critical Procter & Gamble
Publication of SG120901A1 publication Critical patent/SG120901A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG200207219A 1998-04-29 1999-04-27 Process for making 1,3-disubstituted-4-oxocyclic ureas SG120901A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8349398P 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
SG120901A1 true SG120901A1 (en) 2006-04-26

Family

ID=22178700

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200207219A SG120901A1 (en) 1998-04-29 1999-04-27 Process for making 1,3-disubstituted-4-oxocyclic ureas

Country Status (28)

Country Link
US (1) US6414151B1 (ko)
EP (1) EP1075473B1 (ko)
JP (1) JP4549531B2 (ko)
KR (1) KR100400050B1 (ko)
CN (1) CN1298403A (ko)
AR (1) AR015044A1 (ko)
AT (1) ATE366251T1 (ko)
AU (1) AU751681B2 (ko)
BR (1) BR9910074A (ko)
CA (1) CA2330686C (ko)
CO (1) CO5070625A1 (ko)
CZ (1) CZ299163B6 (ko)
DE (1) DE69936449T2 (ko)
DK (1) DK1075473T3 (ko)
ES (1) ES2288020T3 (ko)
HU (1) HUP0102666A3 (ko)
ID (1) ID27452A (ko)
IL (1) IL138404A (ko)
MY (1) MY133753A (ko)
NO (1) NO20005424L (ko)
PE (1) PE20000925A1 (ko)
PL (1) PL197776B1 (ko)
RU (1) RU2194706C2 (ko)
SG (1) SG120901A1 (ko)
SK (1) SK15842000A3 (ko)
TR (1) TR200003137T2 (ko)
WO (1) WO1999055700A1 (ko)
ZA (1) ZA200004712B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ506773A (en) * 1998-04-29 2004-03-26 Procter & Gamble Process for making 1, 3-disubstituted-4-oxocyclic ureas
CN100443473C (zh) * 2005-04-30 2008-12-17 中国药科大学 1-氨基-3-(氮杂环基烷基)-2,4-咪唑二酮的合成方法
TW200840578A (en) * 2006-12-15 2008-10-16 Procter & Gamble Compositions of azimilide dihydrochloride
US20120178762A1 (en) 2006-12-15 2012-07-12 Warner Chilcott Company, Llc Compositions of azimilide dihydrochloride
CN101735205B (zh) * 2009-12-17 2013-05-15 天津药物研究院 盐酸阿齐利特的晶型ⅴ及其制备方法和用途
CN101735202B (zh) * 2009-12-17 2012-05-30 天津药物研究院 盐酸阿齐利特的晶型ⅰ及其制备方法和用途
CN101735203B (zh) * 2009-12-17 2012-05-23 天津药物研究院 盐酸阿齐利特的晶型ⅱ及其制备方法和用途
US10028858B2 (en) 2011-07-11 2018-07-24 Medicines360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321431A1 (en) * 1987-12-16 1989-06-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5462940A (en) * 1991-08-14 1995-10-31 Norwich Eaton Pharmaceuticals, Inc. 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906010A (en) 1974-06-17 1975-09-16 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3919231A (en) 1974-06-17 1975-11-11 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3946049A (en) 1975-04-03 1976-03-23 Morton-Norwich Products, Inc. 5-phenyl-2-furamidoximes
US4001222A (en) 1975-10-14 1977-01-04 Morton-Norwich Products, Inc. 3-(Aminoacyl)-1-{[5-(substituted phenyl)furfurylidene]amino}hydantoins and process for their preparation thereof
JPS5726653A (en) 1980-05-09 1982-02-12 Ciba Geigy Ag Substituted phenyl ether
IL82856A0 (en) 1986-06-26 1987-12-20 Norwich Eaton Pharma Pharmaceutical compositions containing 2-(5-phenyl-2-furanyl)imidazoles and certain such novel compounds
US5019651A (en) 1990-06-20 1991-05-28 Merck & Co., Inc. Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
JP3031973B2 (ja) * 1990-08-16 2000-04-10 富士レビオ株式会社 フェニトイン誘導体
BR9206353A (pt) 1991-08-14 1995-11-07 Procter & Gamble Pharma Uretanos cíclicos utilizáveis como agentes antiarrítmicos e antifibrilatórios
NZ506773A (en) * 1998-04-29 2004-03-26 Procter & Gamble Process for making 1, 3-disubstituted-4-oxocyclic ureas

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321431A1 (en) * 1987-12-16 1989-06-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5462940A (en) * 1991-08-14 1995-10-31 Norwich Eaton Pharmaceuticals, Inc. 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents

Also Published As

Publication number Publication date
IL138404A0 (en) 2001-10-31
AR015044A1 (es) 2001-04-11
JP2002513021A (ja) 2002-05-08
KR100400050B1 (ko) 2003-09-29
CZ299163B6 (cs) 2008-05-07
ATE366251T1 (de) 2007-07-15
EP1075473B1 (en) 2007-07-04
PE20000925A1 (es) 2000-11-17
CA2330686C (en) 2006-09-26
NO20005424D0 (no) 2000-10-27
TR200003137T2 (tr) 2001-02-21
ES2288020T3 (es) 2007-12-16
US6414151B1 (en) 2002-07-02
IL138404A (en) 2004-07-25
KR20010043052A (ko) 2001-05-25
BR9910074A (pt) 2000-12-26
AU751681B2 (en) 2002-08-22
CA2330686A1 (en) 1999-11-04
CO5070625A1 (es) 2001-08-28
WO1999055700A1 (en) 1999-11-04
DK1075473T3 (da) 2007-11-05
HUP0102666A3 (en) 2002-05-28
RU2194706C2 (ru) 2002-12-20
NO20005424L (no) 2000-10-27
DE69936449T2 (de) 2008-03-06
CZ20003951A3 (cs) 2001-08-15
ZA200004712B (en) 2003-02-26
PL197776B1 (pl) 2008-04-30
AU3573599A (en) 1999-11-16
ID27452A (id) 2001-04-12
CN1298403A (zh) 2001-06-06
JP4549531B2 (ja) 2010-09-22
HUP0102666A2 (hu) 2002-03-28
PL343734A1 (en) 2001-09-10
SK15842000A3 (sk) 2001-06-11
MY133753A (en) 2007-11-30
EP1075473A1 (en) 2001-02-14
DE69936449D1 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
PL348827A1 (en) Process for making 2,3-dihalopropanols
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
EP0683024A3 (de) Verfahren zum Herstellen von Formteilen.
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
IL126989A (en) Process for making 4,6-dihydroxypyrimidine
PL343734A1 (en) Process for making 1,3-disubstituted-4-oxocyclic ureas
IL116634A0 (en) Solventles process for making 2,6-difluorobenzonitrile
IL138405A (en) Process for making 1,3-disubstituted-4-oxocyclic ureas
HUP0105180A3 (en) Method for producing 2-amino-4-chloro-1,3,5-triazines
IL141048A0 (en) Process for preparing 3,5-difluoroaniline
HUP9802054A3 (en) Process for producing 4,4,5,5,5-pentafluor-1-pentanol
EP1113002A4 (en) PROCESS FOR PRODUCING O-ALKYL-N-CYANOIMIDATE
EP1061060A4 (en) PROCESS FOR THE PRODUCTION OF 1,2,4-BUTANETRIOL
ZA9710349B (en) Process for making benzisothiazolin-3-ones.
IL146573A0 (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
HUP9802105A3 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
EG22464A (en) Process for making 1,3-disubstituted-4-oxocyclic ureas
HUP0102297A3 (en) Process for preparation of 4,5-epoxymorphinan-6-oxi-glucuronides
HUP9701335A3 (en) Process for producing 1-(3,4-dimethoxy-phenol)-ethanol
GB2336155B (en) Process for producing 1-bromo-4-phenylbutane
EP1061068A4 (en) PRODUCTION OF BENZAMIDOXIMES
GB9817171D0 (en) Process for making 1,5-distributed imidazoles
GB9806786D0 (en) Novel process
HUP0101242A3 (en) Method for producing 2,4-dichloro-5-hydroxyacetanilide
IL130732A0 (en) Method for making 1,2-dibromoindane